Biogen (BIIB) News Today → How Biden has already won 2024 (From Porter & Company) (Ad) Free BIIB Stock Alerts $225.43 -6.56 (-2.83%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 10 at 2:14 AM | americanbankingnews.comWedbush Comments on Biogen Inc.'s FY2027 Earnings (NASDAQ:BIIB)June 9 at 7:37 PM | globenewswire.comFDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's DiseaseJune 9 at 1:28 PM | marketbeat.comOssiam Sells 4,746 Shares of Biogen Inc. (NASDAQ:BIIB)Ossiam trimmed its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 14.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,620 shares of the biotechnology company's stock after selling 4,746 sharesJune 8 at 10:28 AM | marketbeat.comEpoch Investment Partners Inc. Has $71.74 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB)Epoch Investment Partners Inc. lifted its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 49.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 277,224 shares of the biotechnology company's stock after puJune 8 at 5:11 AM | globenewswire.comBIOGEN CASE DEADLINE: Biogen Inc. (Nasdaq: BIIB) Investors are Reminded of Upcoming July 2024 Legal Deadline and Encouraged to Contact BFA LawJune 7 at 6:13 PM | prnewswire.comBiogen Inc. Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against (BIIB) - Contact Kessler Topaz Meltzer & Check, LLPJune 7 at 5:12 PM | globenewswire.comBIIB Class Action Reminder: Contact Robbins LLP for Information About Your Rights Against Biogen Inc.June 7 at 1:27 PM | globenewswire.comLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) ShareholdersJune 7 at 12:10 PM | businesswire.comINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with Losses to Contact the FirmJune 7 at 9:38 AM | marketbeat.comPinebridge Investments L.P. Has $5.20 Million Holdings in Biogen Inc. (NASDAQ:BIIB)Pinebridge Investments L.P. grew its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 51.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,104 shares of the biotechnoloJune 7 at 1:48 AM | americanbankingnews.comBiogen (NASDAQ:BIIB) Stock Rating Reaffirmed by Royal Bank of CanadaJune 6, 2024 | marketbeat.comCibc World Markets Corp Raises Stock Position in Biogen Inc. (NASDAQ:BIIB)Cibc World Markets Corp increased its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 60.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,452 shares of the biotechnology company's stock after puJune 6, 2024 | globenewswire.comClass Action Filed Against Biogen Inc. (BIIB) - July 22, 2024 Deadline to Join – Contact The Gross Law FirmJune 6, 2024 | prnewswire.comBiogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIBJune 6, 2024 | globenewswire.comBIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!June 5, 2024 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by Armistice Capital LLCArmistice Capital LLC lessened its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 27.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 200,000 shares of the biotechJune 5, 2024 | prnewswire.comFINAL DEADLINE RAPIDLY APPROACHING: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the FirmJune 5, 2024 | marketbeat.comRoyal Bank of Canada Reiterates "Outperform" Rating for Biogen (NASDAQ:BIIB)Royal Bank of Canada reaffirmed an "outperform" rating and set a $317.00 price objective on shares of Biogen in a report on Wednesday.June 5, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines – BIIBJune 4, 2024 | businesswire.comGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)June 4, 2024 | prnewswire.comClass Action Filed Against Biogen Inc. (BIIB) - July 22, 2024 Deadline to Join - Contact Levi & KorsinskyJune 4, 2024 | globenewswire.comBIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Biogen Inc.June 3, 2024 | businesswire.comRobbins LLP Urges BIIB Investors With Large Losses to Contact the Firm for Information About the Biogen Inc. Class ActionJune 3, 2024 | marketbeat.comCarmignac Gestion Increases Holdings in Biogen Inc. (NASDAQ:BIIB)Carmignac Gestion increased its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 16.9% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 361,395 shares of the biotechnology company's stock after acquiring an additional 52,295 shJune 3, 2024 | globenewswire.comBIOGEN 50 DAY NOTICE: Investors of Biogen Inc. (Nasdaq: BIIB) are Encouraged to Contact BFA Law Before July 2024 Deadline in Securities Fraud Class ActionJune 3, 2024 | globenewswire.comBiogen Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law FirmJune 3, 2024 | businesswire.comDeadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)June 3, 2024 | benzinga.comBiogen Shares Surge Following Collaboration With Delta Flight Products: What You Need To KnowJune 3, 2024 | globenewswire.comNASDAQ: BIIB: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Biogen Inc.June 3, 2024 | globenewswire.comBiogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air TravelJune 2, 2024 | globenewswire.comBIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJune 1, 2024 | globenewswire.comBIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the FirmJune 1, 2024 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Short Interest Up 10.5% in MayBiogen Inc. (NASDAQ:BIIB - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 3,480,000 shares, a growth of 10.5% from the April 30th total of 3,150,000 shares. Based on an average daily volume of 1,220,000 shares, the days-to-cover ratio is currently 2.9 days. Approximately 2.4% of the company's shares are short sold.June 1, 2024 | marketbeat.comBank of Nova Scotia Purchases 130,169 Shares of Biogen Inc. (NASDAQ:BIIB)Bank of Nova Scotia lifted its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 432.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 160,263 shares of the biotechnology company's stock aMay 31, 2024 | businesswire.comNASDAQ: BIIB: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Biogen Inc.May 31, 2024 | marketbeat.comEvoke Wealth LLC Invests $2.81 Million in Biogen Inc. (NASDAQ:BIIB)Evoke Wealth LLC bought a new stake in Biogen Inc. (NASDAQ:BIIB - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 10,851 shares of the biotechnology company's stock, valued at approximaMay 31, 2024 | benzinga.comEurope Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative DisorderMay 30, 2024 | seekingalpha.comEU approves Biogen treatment for genetic form of ALSMay 30, 2024 | businesswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) InvestorsMay 30, 2024 | reuters.comEuropean Commission grants marketing approval to Biogen's ALS drugMay 30, 2024 | marketbeat.comTreasurer of the State of North Carolina Buys 3,609 Shares of Biogen Inc. (NASDAQ:BIIB)Treasurer of the State of North Carolina grew its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 3.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 95,852 shares of the biotechnology company's stock after acquiring an additionaMay 30, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIBMay 30, 2024 | globenewswire.comBiogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALSMay 30, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) InvestorsMay 30, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) InvestorsMay 30, 2024 | businesswire.comBIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!May 30, 2024 | prnewswire.comBIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!May 29, 2024 | sg.finance.yahoo.comBIIB Jun 2024 350.000 putMay 29, 2024 | marketbeat.comBiogen (NASDAQ:BIIB) Receives Outperform Rating from Royal Bank of CanadaRoyal Bank of Canada restated an "outperform" rating and issued a $317.00 price objective on shares of Biogen in a report on Wednesday.May 29, 2024 | sg.finance.yahoo.comBIIB Jan 2026 120.000 call Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address How Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future. Click here to watch this now before it’s too late. BIIB Media Mentions By Week BIIB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.170.76▲Average Medical News Sentiment BIIB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼3017▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: American Electric Power News Today Teva Pharmaceutical Industries News Today Pinnacle West Capital News Today CRISPR Therapeutics News Today Portland General Electric News Today Denali Therapeutics News Today Sanofi News Today Vertex Pharmaceuticals News Today Regeneron Pharmaceuticals News Today Gilead Sciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored